The Healthcare Data

Merck Gets Positive EU CHMP Opinion for WELIREG®

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the conditional approval of WELIREG® (belzutifan). This oral…